Latest News About - Hanta Fever
Tools
Tuesday, January 26, 2021
11:11:00 PM CET
Language Selection
For any category/filter, users can choose:
- the language of the categorized news items (e.g. fr and de to display only those news items in French and German)
- the language of the user interface (e.g. it for Italian)
In Top Stories, the user can display the largest clusters of news items for one language only (e.g. en shows all clusters in English)
Country Selection
Users can choose:
- country mentioned in the news item (articles about a country)
- country in which the news item was published (articles from a country)
Languages 
Select your languages
Interface:
Most reported countries (24h)
AlertLevel (24h)
Previous 14 days average
Alert level:
high
medium
low
Extracted quotes
Sophie Schwab erklärte: "Durch die Einschränkungen waren Spaziergänge, Sport und Bewegung im Freien für viele Menschen beliebte Alternativen" 
suddeutsche Sunday, January 24, 2021 4:40:00 PM CET
Sophie Schwab erläuterte: "Zur positiven Entwicklung bei den Masern hat neben den Kontaktbeschränkungen und Abstandsregeln sicher auch das seit 1. März 2020 geltende Masernschutzgesetz beigetragen"
suddeutsche Sunday, January 24, 2021 4:40:00 PM CET
Markus Soeder sagte: "Mein dringender Rat ist, wir sollten tun, was notwendig ist"
suddeutsche Sunday, January 24, 2021 4:40:00 PM CET
Sophie Schwab erklärte: «Durch die Einschränkungen waren Spaziergänge, Sport und Bewegung im Freien für viele Menschen beliebte Alternativen»
zeit Friday, January 22, 2021 6:13:00 AM CET
Sophie Schwab erläuterte: «Zur positiven Entwicklung bei den Masern hat neben den Kontaktbeschränkungen und Abstandsregeln sicher auch das seit 1. März 2020 geltende Masernschutzgesetz beigetragen»
zeit Friday, January 22, 2021 6:13:00 AM CET
Rainer Lichtenberger said: "We would like to warmly thank Prof. Stephan Ludwig and Emilie Hofstetter for their strong commitment over the last years since the foundation of the Company and their advice in advancing Atriva's scientific and corporate achievements to clinical trials. Prof. Ludwig will continue to offer his scientific insight and expertise as virologist in the Advisory Board, which are highly valuable for our future development,"
4-traders Wednesday, January 20, 2021 9:04:00 AM CET
Ulrich Dauer said: "I am excited to support Atriva,"
4-traders Wednesday, January 20, 2021 9:04:00 AM CET
Jason Botten said: "We've made great strides to understand how this protein regulates the infectivity of viral particles,"
4-traders Tuesday, January 19, 2021 5:49:00 PM CET
Eric Núñez comentó: "Nos llegan muchas denuncias en este tema. Es responsabilidad de cada ciudadano cuidar del ambiente en que se vive; los animales tienen su función y siempre que se elimina un espécimen, se causa un desequilibrio"
panamaamerica Sunday, January 10, 2021 6:41:00 AM CET
Lisandro Bonelli señaló: “vinimos a ver cómo se está desarrollando el plan de inversiones que anunció el presidente de la Nación, Alberto Fernández, con el ministro de Salud, Ginés González García, al inicio de la gestión. El objetivo que tuvimos es volver a poner en marcha la planta de vacunas contra la fiebre hemorrágica”
argentina-gob Friday, January 8, 2021 10:40:00 PM CET
Bill Gates disclosed: “The latest on the innovations that will let us go back to normal”
thenewsnigeria Friday, January 8, 2021 12:55:00 PM CET
Bill Gates disclosed: “more than 1.6 million people have died in the COVID-19 pandemic, more than 75 million cases and tens of trillions of dollars in economic damages”
thenewsnigeria Friday, January 8, 2021 12:55:00 PM CET
Eduardo Herrero dijo: “La lectura que hacemos nosotros del hantavirus en nuestra zona es que han disminuido los casos , en lo que va desde el año pasado tuvimos sólo este caso, porque esta persona empezó el 31 de diciembre”
entornointeligente Thursday, January 7, 2021 12:44:00 AM CET
Rainer Lichtenberger said: "We are delighted to receive this approval from the German authorities and are grateful for their positive feedback and encouragement. At the same time, we are preparing for additional approvals to involve clinical centers in other European and Non-European countries,"
direktbroker Tuesday, January 5, 2021 11:25:00 AM CET
Martin Witzenrath said: "There is an urgent need for an effective treatment to stop COVID-19 patients from progressing to critical conditions requiring intensive care and causing potentially permanent health issues and even death. ATR-002's capability to both fight the virus and combat the excessive immune response that we see in patients with moderate or severe COVID-19 makes it a very promising therapeutic candidate for this patient population. We are confident that this pivotal study will quickly lead to an effective treatment for the patients most severely affected by this disease"
direktbroker Tuesday, January 5, 2021 11:25:00 AM CET
Martin Bauer concluded: "Starting a Phase II clinical trial with ATR-002 in patients suffering from COVID-19 is an important step for Atriva and we have every confidence in the expertise and support of the Charit? medical team to lead this study. With this trial, we intend to rapidly advance our drug candidate so patients in need for therapeutic options can potentially benefit from it. Ultimately, our goal is to provide a safe antiviral that can help treat not only infections with SARS-CoV-2, but also influenza and future emerging RNA virus outbreaks,"
direktbroker Tuesday, January 5, 2021 11:25:00 AM CET
Rainer Lichtenberger said: "We are delighted to receive this approval from the German authorities and are grateful for their positive feedback and encouragement. At the same time, we are preparing for additional approvals to involve clinical centers in other European and Non-European countries,"
4-traders Tuesday, January 5, 2021 9:17:00 AM CET
Martin Witzenrath said: "There is an urgent need for an effective treatment to stop COVID-19 patients from progressing to critical conditions requiring intensive care and causing potentially permanent health issues and even death. ATR-002's capability to both fight the virus and combat the excessive immune response that we see in patients with moderate or severe COVID-19 makes it a very promising therapeutic candidate for this patient population. We are confident that this pivotal study will quickly lead to an effective treatment for the patients most severely affected by this disease"
4-traders Tuesday, January 5, 2021 9:17:00 AM CET
Martin Bauer concluded: "Starting a Phase II clinical trial with ATR-002 in patients suffering from COVID-19 is an important step for Atriva and we have every confidence in the expertise and support of the Charité medical team to lead this study. With this trial, we intend to rapidly advance our drug candidate so patients in need for therapeutic options can potentially benefit from it. Ultimately, our goal is to provide a safe antiviral that can help treat not only infections with SARS-CoV-2, but also influenza and future emerging RNA virus outbreaks,"
4-traders Tuesday, January 5, 2021 9:17:00 AM CET
Royston Smith added: “Crewing is an operational issue. Fire call outs are down by around a half in the last ten years thanks in part to smoke detectors and sprinkler systems. New technology means pumps can sometimes operate with fewer firefighters. However, pumps and crew off the run are of concern but the HFR authority can generate additional funds from council tax if they wish”
dailyecho Friday, January 1, 2021 9:43:00 AM CET
Most associated names
Daily number of articles in this category
Trend data not available for this selection.
Most active sources for this category
Contact: 